1.Worgall S, Crystal RG. Chapter 34 - Gene Therapy. In: Lanza R, Langer R, Vacanti J, editors. Principles of Tissue Engineering (Fourth Edition). Boston: Academic Press; 2014. p. 657-86.
2.Gonçalves GAR, Paiva RMA. Gene therapy: advances, challenges and perspectives. Einstein (Sao Paulo, Brazil). 2017;15(3):369-75.
3.Misra S. Human gene therapy: a brief overview of the genetic revolution. The Journal of the Association of Physicians of India. 2013;61(2):127-33.
4.Human Genome Editing: Science, Ethics, and Governance. Washington DC: 2017 by the National Academy of Sciences; 2017.
5.Delhove J, Osenk I, Prichard I, Donnelley M. Public Acceptability of Gene Therapy and Gene Editing for Human Use: A Systematic Review. Human gene therapy. 2020;31(1-2):20-46.
6.Dunbar CE, High KA, Joung JK, Kohn DB, Ozawa K, Sadelain M. Gene therapy comes of age. Science (New York, NY). 2018;359(6372).
7.Keeler A, ElMallah M, Flotte T. Gene Therapy 2017: Progress and Future Directions. Clinical and Translational Science. 2017;10(4):242-8.
8.Kumar SR, Markusic DM, Biswas M, High KA, Herzog RW. Clinical development of gene therapy: results and lessons from recent successes. Molecular therapy Methods & clinical development. 2016;3:16034.
9.Kumar A, Sharma P, Bhandari A. Gene Therapy: An Updated Review. European Journal of Biotechnology and Bioscience. 2014;1(3):42-53.
10.Goswami R, Subramanian G, Silayeva L, Newkirk I, Doctor D, Chawla K, et al. Gene Therapy Leaves a Vicious Cycle. Frontiers in oncology. 2019;9:297.
11.Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Research & Therapy. 2019;10(1):68.
12.Alenzi F, Lotfy M, Tamimi W, Wyse R. Review: Stem Cells and Gene Therapy. Laboratory hematology : official publication of the International Society for Laboratory Hematology. 2010;16:53-73.
13.Biehl JK, Russell B. Introduction to stem cell therapy. J Cardiovasc Nurs. 2009;24(2):98-105.
14.Muñoz Ruiz M, Regueiro JR. New Tools in Regenerative Medicine: Gene Therapy. In: López-Larrea C, López-Vázquez A, Suárez-Álvarez B, editors. Stem Cell Transplantation. New York, NY: Springer US; 2012. p. 254-75.
15.Gaipov A, Myngbay A. Stem Cells Therapy in General Medicine. European Journal of General Medicine. 2018;15:50-3.
16.Resnik DB. Bioethics of Gene Therapy.  eLS(2012).
17.Deakin CT, Alexander IE, Kerridge I. Accepting risk in clinical research: is the gene therapy field becoming too risk-averse? Mol Ther. 2009;17(11):1842-8.
18.Kohn DB, Porteus MH, Scharenberg AM. Ethical and regulatory aspects of genome editing. Blood. 2016;127(21):2553-60.
19.McFarland TJ, Stout JT. CHAPTER 41 - Ocular gene therapy. In: Nguyen QD, Rodrigues EB, Farah ME, Mieler WF, editors. Retinal Pharmacotherapy. Edinburgh: W.B. Saunders; 2010. p. 285-91.
20.Greely HT. Ethical Issues in the ‘New’ Genetics. In: Smelser NJ, Baltes PB, editors. International Encyclopedia of the Social & Behavioral Sciences. Oxford: Pergamon; 2001. p. 4762-70.
21.Sade RM, Khushf G. Gene therapy: ethical and social issues. Journal of the South Carolina Medical Association (1975). 1998;94(9):406-10.
22.Thiele F. Bioethics: Examples from the Life Sciences. In: Smelser NJ, Baltes PB, editors. International Encyclopedia of the Social & Behavioral Sciences. Oxford: Pergamon; 2001. p. 1190-5.
23.Skorecki K, Galun E. 43 - Cell and Gene Therapy. In: Goldman L, Schafer AI, editors. Goldman’s Cecil Medicine (Twenty Fourth Edition). Philadelphia: W.B. Saunders; 2012. p. 203-11.
24.Verma IM. Germline Gene Therapy: Yes or No? Molecular Therapy. 2001;4(1):1.
25.Häyry M. Genetic Engineering of Human Beings. In: Chadwick R, editor. Encyclopedia of Applied Ethics (Second Edition). San Diego: Academic Press; 2012. p. 436-44.
26.Marshall D, Sharpe M, Ward S. Cell & gene therapies and the evolving role of personalized medicine. Cell and Gene Therapy Insights. 2016;2:277-86.
27.Swinney DC, Xia S. The discovery of medicines for rare diseases. Future Med Chem. 2014;6(9):987-1002.
28.Personalized medicine : legal and ethical challenges. 2020.
29.Noori-Daloii MR, Zafari N. The personalized medicine: today and tomorrow. MEDICAL SCIENCES JOURNAL. 2019;29(1):1-17.
30.Ventola CL. The role of pharmacogenomic biomarkers in predicting and improving drug response: part 2: challenges impeding clinical implementation. P t. 2013;38(10):624-7.
31.Schwab M, Schaeffeler E. Pharmacogenomics: a key component of personalized therapy. Genome Med. 2012;4(11):93.
32.Kiwanuka E, Hackl F, Nowinski D, Eriksson E. 15 - Molecular and gene therapies for wound repair. In: Farrar D, editor. Advanced Wound Repair Therapies: Woodhead Publishing; 2011. p. 395-415.
33.Macpherson I, Roqué MV, Segarra I. Ethical Challenges of Germline Genetic Enhancement. Frontiers in Genetics. 2019;10(767).
34.Khan SH. Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application. Molecular therapy Nucleic acids. 2019;16:326-34.
35.Kushner J. The ethics of personalized medicine. Personalized Medicine Universe. 2014;3:42-5.
36.Patil S, Al-Zoubi IA, Raghuram PH, Misra N, Yadav N, Alam M. Gene therapy: A comprehensive review. International Medical Journal. 2018;25:361-4.
37.Cordeiro JV. Ethical and legal challenges of personalized medicine: Paradigmatic examples of research, prevention, diagnosis and treatment. Revista Portuguesa de Saúde Pública. 2014;32(2):164-80.